Previous 10 | Next 10 |
Currently trading at less than $250, ResMed Inc. (RMD) exhibited solid fundamental performance in its last reported quarter based on its strong sales growth across its product portfolio. So, given favorable analysts' sentiments about the stock and the company’s strong profitability, is...
ICU Medical Completes the Acquisition of Smiths Medical from Smiths Group plc The addition of Smiths Medical syringe and ambulatory infusion devices, vascular access, and vital care products to the ICU Medical portfolio creates a leading infusion therapy company with a more robu...
Dental-industry-focused medical device company BIOLASE (BIOL) recently received an extension from Nasdaq to meet the exchange’s minimum bid price requirement and reported revenue growth in the third quarter. However, is it wise to add the stock to one’s portfolio even though BIO...
A global leader in medical technology, Medtronic’s (MDT) differentiated portfolio of medical devices and increased international market penetration have boosted investor confidence in the stock. Given the company’s robust revenue growth across all segments and the pent-up demand...
Medical device company DexCom (DXCM) garnered investors' attention over the past year due to its advancement in its continuous glucose monitoring (CGM) technology and coverage expansion. However, the growing competition in the diabetes management space is driving down DXCM’s shares. Mo...
SAN CLEMENTE, Calif., Dec. 29, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the J.P....
The following slide deck was published by ICU Medical, Inc. in conjunction with their 2021 Q3 earnings call. For further details see: ICU Medical, Inc. 2021 Q3 - Results - Earnings Call Presentation
Image source: The Motley Fool. ICU Medical, inc (NASDAQ: ICUI) Q3 2021 Earnings Call Nov 3, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: ICU Medical, inc (ICUI) Q3 2021 Earnings Call Transcript
ICU Medical, Inc. (ICUI) Q3 2021 Earnings Conference Call November 03, 2021 04:30 AM ET Company Participants John Mills – Managing Partner Vivek Jain – Chairman and Chief Executive Officer Brian Bonnell – Chief Financial Officer Conference Call Participants Larry Solow ...
ICU Medical (NASDAQ:ICUI): Non-GAAP EPS of $2.07 beats by $0.27; GAAP EPS of $1.43 beats by $0.06. Revenue of $336.1M beats by $17.8M. Press Release For further details see: ICU Medical EPS beats by $0.27, beats on revenue
News, Short Squeeze, Breakout and More Instantly...
SAN CLEMENTE, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2024 earnings release and conference call. The Company will release its ...
SAN CLEMENTE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2024. First Quarter 2024 Results First...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...